John Hancock Comvest Private Income Fund 8-K

What Happened

• John Hancock Comvest Private Income Fund (JHCPIF) filed an 8-K on June 23, 2026 reporting that it entered into an Agreement and Plan of Merger dated June 22, 2026 to combine with Manulife Private Credit Fund (MPCF). The transaction is a two-step merger in which JHCPIF’s wholly owned Merger Sub will merge into MPCF, and then MPCF will merge into JHCPIF, with JHCPIF surviving.
• The parties intend the transaction to be a tax-free reorganization under Section 368(a). The closing is currently anticipated in the third quarter of 2026 and is subject to customary conditions and approvals, including shareholder votes, effectiveness of a registration statement (Form N-14), Hart-Scott-Rodino clearance, and a tax opinion.

Key Details

• Date filed: 8-K dated June 23, 2026; Merger Agreement dated June 22, 2026.
• Exchange consideration: Each MPCF Class NAV common share will convert into JHCPIF Class I common shares using an Exchange Ratio equal to MPCF Per Share NAV divided by JHCPIF Per Share NAV (rounded to 4 decimals). Final shares issued after a Final Determination Date based on mutually calculated NAVs.
• No fractional shares will be issued; cash will be paid in lieu of fractional shares.
• Closing conditions include shareholder approvals of both funds, registration statement effectiveness, required regulatory approvals (including HSR), accuracy of reps/warranties, a tax opinion, and no Material Adverse Effect.
• Termination/timeout: either party may terminate if the Merger is not completed by June 22, 2027. Transaction costs are to be borne equally by the two funds’ advisers.

Why It Matters

• This is a material transaction for investors in both BDCs (business development companies). If approved and completed, MPCF shareholders will become JHCPIF shareholders via an NAV-based share exchange, which could change the combined fund’s size, portfolio mix, and shareholder base.
• Key near-term milestones for investors to watch: the filing and mailing of the joint proxy and Form N-14, shareholder votes, the Final Determination Date and resulting Exchange Ratio, and receipt of the tax opinion and regulatory clearances.